• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例促甲状腺激素/生长激素分泌型垂体瘤与甲状腺乳头状癌并存的病例:发病机制及管理面临的挑战

A case of coexistence of TSH/GH-secreting pituitary tumor and papillary thyroid carcinoma: Challenges in pathogenesis and management.

作者信息

Kiatpanabhikul Phatharaporn, Shuangshoti Shanop, Chantra Kraisri, Navicharern Patpong, Kingpetch Kanaungnit, Houngngam Natnicha, Snabboon Thiti

机构信息

Department of Medicine, Charoenkrung pracharak Hospital, Medical Service Department, Bangkok Metropolitan Administration, Bangkok, Thailand.

Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

出版信息

J Clin Neurosci. 2017 Jul;41:78-80. doi: 10.1016/j.jocn.2017.02.050. Epub 2017 Mar 6.

DOI:10.1016/j.jocn.2017.02.050
PMID:28279554
Abstract

Co-existence of thyrotropin/growth hormone-secreting pituitary adenoma with differentiated thyroid carcinoma is exceedingly rare, with less than 15 cases having been reported. Its clinical presentation and treatment strategy are challenging. We report a case of pituitary macroadenoma, with clinical syndromes of acromegaly and hyperthyroidism, and a thyroid nodule, with cytologically confirmed to be a papillary thyroid carcinoma. Clinical implications, focusing on the strategy for proper management, and possible pathogenesis were discussed.

摘要

促甲状腺激素/生长激素分泌型垂体腺瘤与分化型甲状腺癌并存极为罕见,报告的病例不足15例。其临床表现和治疗策略具有挑战性。我们报告一例垂体大腺瘤,伴有肢端肥大症和甲状腺功能亢进的临床综合征,以及一个甲状腺结节,经细胞学检查确诊为乳头状甲状腺癌。本文讨论了其临床意义,重点是合理管理策略以及可能的发病机制。

相似文献

1
A case of coexistence of TSH/GH-secreting pituitary tumor and papillary thyroid carcinoma: Challenges in pathogenesis and management.一例促甲状腺激素/生长激素分泌型垂体瘤与甲状腺乳头状癌并存的病例:发病机制及管理面临的挑战
J Clin Neurosci. 2017 Jul;41:78-80. doi: 10.1016/j.jocn.2017.02.050. Epub 2017 Mar 6.
2
A challenging TSH/GH co-secreting pituitary adenoma with concomitant thyroid cancer; a case report and literature review.伴有甲状腺癌的 TSH/GH 共分泌垂体腺瘤:病例报告及文献复习。
BMC Endocr Disord. 2021 Aug 30;21(1):177. doi: 10.1186/s12902-021-00839-x.
3
Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report.异位分泌促甲状腺激素的垂体腺瘤合并甲状腺乳头状癌:病例报告
Medicine (Baltimore). 2017 Dec;96(50):e8912. doi: 10.1097/MD.0000000000008912.
4
A Rare Case of Thyrotropin-Secreting Pituitary Adenoma Coexisting with Papillary Thyroid Carcinoma Presenting with Visual Disturbance without Hyperthyroidism.一例罕见的促甲状腺素分泌型垂体腺瘤合并甲状腺乳头状癌病例,表现为视力障碍且无甲状腺功能亢进。
World Neurosurg. 2018 Nov;119:394-399. doi: 10.1016/j.wneu.2018.07.274. Epub 2018 Aug 7.
5
Hyperthyroidism in a patient with TSH-producing pituitary adenoma coexisting with thyroid papillary adenocarcinoma.促甲状腺激素分泌型垂体腺瘤合并甲状腺乳头状腺癌患者的甲状腺功能亢进症。
Endocr J. 2000 Dec;47(6):731-8. doi: 10.1507/endocrj.47.731.
6
Coexistence of thyrotropin-producing pituitary adenoma with papillary adenocarcinoma of the thyroid--a case report and surgical strategy.促甲状腺素分泌型垂体腺瘤与甲状腺乳头状腺癌并存——病例报告及手术策略
Pituitary. 2001 Sep;4(4):271-4. doi: 10.1023/a:1020758716771.
7
[A case of GH and TSH secreting pituitary macroadenoma].[一例生长激素和促甲状腺激素分泌型垂体大腺瘤]
Przegl Lek. 2006;63(2):106-8.
8
Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.促甲状腺激素分泌型垂体腺瘤与格雷夫斯病同时存在:一例报告
J Med Case Rep. 2017 Jan 6;11(1):9. doi: 10.1186/s13256-016-1172-4.
9
Management of coexisting thyrotropin/growth-hormone-secreting pituitary adenoma and papillary thyroid carcinoma: a therapeutic challenge.共存的促甲状腺激素/生长激素分泌垂体腺瘤和甲状腺乳头状癌的治疗管理:一项治疗挑战。
Thyroid. 2010 Jan;20(1):99-103. doi: 10.1089/thy.2009.0160.
10
Concurrent Graves' Disease and TSH Secreting Pituitary Adenoma Presenting Suppressed Thyrotropin Levels: A Case Report and Review of the Literature.同时患有 Graves 病和促甲状腺激素分泌垂体腺瘤,表现为促甲状腺激素水平受抑制:病例报告及文献复习。
Front Endocrinol (Lausanne). 2020 Aug 6;11:523. doi: 10.3389/fendo.2020.00523. eCollection 2020.

引用本文的文献

1
Diagnostic Challenges of Thyrotropin-Secreting Hypophyseal Macroadenoma Associated with Papillary Thyroid Carcinoma: Case Report and Literature Review.促甲状腺素分泌型垂体大腺瘤合并甲状腺乳头状癌的诊断挑战:病例报告及文献综述
Diagnostics (Basel). 2025 May 23;15(11):1313. doi: 10.3390/diagnostics15111313.
2
Clinical features of pituitary carcinoma: analysis based on a case report and literature review.垂体癌的临床特征:基于病例报告和文献复习的分析。
Front Endocrinol (Lausanne). 2024 Oct 31;15:1440247. doi: 10.3389/fendo.2024.1440247. eCollection 2024.
3
Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center.
GH/TSH 共分泌垂体腺瘤的临床特征和治疗结果:单中心经验。
Front Endocrinol (Lausanne). 2023 May 30;14:1197244. doi: 10.3389/fendo.2023.1197244. eCollection 2023.
4
Simultaneous Coexistence of Thyrotropin-Prolactin-Secreting Adenoma and Papillary Thyroid Carcinoma.促甲状腺素-催乳素分泌性腺瘤与甲状腺乳头状癌同时并存
Case Rep Endocrinol. 2021 Nov 30;2021:6564765. doi: 10.1155/2021/6564765. eCollection 2021.
5
Clinical characteristics and treatment outcomes in acromegaly, a retrospective single-center case series from Thailand.肢端肥大症的临床特征和治疗结局:来自泰国的回顾性单中心病例系列研究。
Pan Afr Med J. 2021 Sep 10;40:31. doi: 10.11604/pamj.2021.40.31.29920. eCollection 2021.